Oxycodone Hydrochloride Capsule
NDC Package 40032-950-03
Package Information
Oxycodone Hydrochloride capsules is oxycodone hydrochloride capsule is an opioid analgesic, indicated for the management of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. This formulation utilizes a capsule delivery system. Marketed by Novel Laboratories, Inc., this product is identified by NDC 40032-950 and is authorized under FDA application ANDA204752.
Identification & Billing
- RxCUI: 1049696 - oxyCODONE HCl 5 MG Oral Capsule
- RxCUI: 1049696 - oxycodone hydrochloride 5 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 40032 - Novel Laboratories, Inc.
- 40032-950 - Oxycodone Hydrochloride
- 40032-950-03 - 30 CAPSULE in 1 BOTTLE
- 40032-950 - Oxycodone Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (40032-950). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 40032-950-03 identifies a specific commercial package of 30 capsule in 1 bottle of Oxycodone Hydrochloride, a human prescription drug labeled by Novel Laboratories, Inc.. This capsule is formulated for oral use and contains oxycodone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novel Laboratories, Inc. on August 24, 2015. The current certification is valid through December 31, 2026.
How is this Novel Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 40032095003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.